The creation of sialoliths in the ductal system of major salivary glands causes characteristic symptoms due to the obstruction of the flow of produced saliva. If sialolithiasis is not treated early obstructive sialadenitis will develop and its repeated relapses may lead to fibrosis and degeneration of glandular parenchyma. In this study we present the method of intraglandular injection of biotherapeutic solution (1.000.000 I.U. penicillin G in 5 cc normal saline) to achieve treatment of obstructive sialadenitis and rejection of the sialolith. Our results as shown in tables I and II and in figures 1-9 are very encouraging. From the conclusions drawn it looks like this method can be recommended as an optional solution to surgery (lithectomy-adenectomy) under the conditions mentioned in the discussion.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysis.
Eur Arch Otorhinolaryngol
December 2024
Department of Otorhinolaryngology and Head- Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
Purpose: Orocervical (OCF) or pharyngocutaneous fistula (PCF) are one of the disastrous complications of head and neck cancer surgery. Conventional standards of management are predominantly conservative. Though a majority of such patients respond to conservative management, it nevertheless causes significant delay in wound healing.
View Article and Find Full Text PDFTreatment of Intractable Aspiration - Combined Open Medialization Thyroplasty with Intraglandular Botulinum Toxin Injection.
J Laryngol Otol
November 2024
Department of Otolaryngology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia.
A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.
BMC Cancer
July 2024
ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Radiotherapy in patients with head and neck cancer fairly leads to xerostomia, profoundly affecting their quality of life. With limited effective preventive and therapeutic methods, attention has turned to exploring alternatives. This article outlines how intraglandular injection of mitochondria-boosting agents can serve as a potential strategy to reduce salivary acinar damage.
View Article and Find Full Text PDFBotulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendations.
Front Neurol
December 2023
Specialist Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogtareuth, Germany.
Article Synopsis
- - Sialorrhea is a chronic condition characterized by excessive saliva production, impacting patients' health and quality of life, with several treatment options available, including non-drug methods and medications.
- - Recent Phase III trials have led to the approval of IncobotulinumtoxinA (Xeomin®) in the USA and EU for treating chronic sialorrhea in both adults and children, highlighting the growing interest in Botulinum Neurotoxin A (BoNT/A) injections.
- - This review outlines a comprehensive framework for managing sialorrhea, providing updates on treatment recommendations for physicians, patient selection criteria, dosing guidelines, and the safety and long-term benefits of BoNT/A injections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!